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http://dx.doi.org/10.1016/j.pedneo.2Background: Late-onset sepsis (LOS) in neonates with patent ductus arteriosus (PDA) may
predispose them to more complicated hospital courses. The objective of this study was to
determine the incidence, the distribution of pathogens, and the clinical features of LOS in
neonates with PDA and analyze their outcomes.
Methods: The medical records were reviewed retrospectively of infants with PDA and LOS who
were hospitalized in NICUs of Chang Gung Children’s Hospital between January 2003 and
December 2009. The clinical features of these infants were compared with a group of gesta-
tional age and birth body weight-matched neonates with LOS during the same period.
Results: During this period, 224 neonates were found to have at least one event of blood-
culture proven LOS and 79 (35.3%) were documented to have PDA. Although most LOS episodes
(85/104, 81.7%) in neonates with PDA occurred after closure of PDA, neonates with PDA had
a significantly higher rate of bronchopulmonary dysplasia (81.0% vs. 61.0%, p Z 0.002) and
a relatively higher rate of recurrent sepsis (25.3% vs. 15.2%, p Z 0.079) than those without
PDA. Longer durations of ventilator support and hospital stay were also noted in neonates with
PDA as compared to those without (p Z 0.001 and 0.005, respectively).Pediatric Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, 5 Fu Shin
n.
.org.tw (S.-M. Chu).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
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310 P.-J. Chiang et alConclusion: In neonates with LOS, the presence of PDA, even though it is aggressively treated
with indomethacin or surgical intervention, may still contribute to the complexity of hospital-
ization. Close monitoring and aggressive treatments are warranted in these neonates with PDA.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Late-onset sepsis (LOS) is a frequent and significant cause
of morbidity and mortality in neonatal intensive care units
(NICUs), especially in extremely preterm or very low birth
weight (VLBW) infants.1,2 Many NICUs have focused on
various strategies in order to decrease the prevalence of
nosocomial infection or device-associated bloodstream
infection,3e5 but 15% to 25% of infants who survived beyond
7 days were found to have at least one event of blood
culture-proven LOS.6e8 VLBW and extremely preterm
neonates have been found to be at higher risk of experi-
encing LOS,9e11 and some studies have found a relatively
higher mortality rate when they had LOS.2,12 Underlying
relative immunocompromise, immature organ functions,
and existence of central venous catheters or endotracheal
tubes accounted for these results.
Infants with congenital heart defects (CHD) are approx-
imately twice as likely to be small for gestational age as
normal populations.13,14 Except for the high prevalence
(13.08/1000 live births) reported in Taiwan,15 the incidence
of CHD is thought to be around 5 to 8/1000 live births.16,17
The patent ductus arteriosus (PDA) is noted to be much
more prevalent in premature or VLBW infants.18 Around
one-third of VLBW infants can be expected to have
a persistent PDA,19 which is originally a physiologic shunt in
the first 3 days of life in healthy term and preterm newborn
infants. 55% of infants who weigh <1000 g (extremely low
birth weight) have also been described to have a symptom-
atic PDA that ultimately requires medical treatment.20,21
These extremely preterm or VLBW infants usually have
a persistent PDA and are much more likely to experience
LOS than late-preterm infants.9e11 The occurrence of LOS
may result in a complicated hospital course if a preterm
infant has a hemodynamically significant PDA, which usually
manifests after the first week of life. The purpose of this
study was to investigate the impact of PDA in neonates with
LOS and determine the appropriate management when
a neonate has symptomatic PDA and experiences LOS.
2. Patients and Methods
2.1. Study population
A retrospective study was conducted over a 7-year period
between January 2003 and December 2009 in a tertiary
NICU of Chang Gung Children’s Hospital (CGMH), a 49-bed
NICU medical center in northern Taiwan. The study was
approved by the Institutional Review Board of CGMH. A list
of neonatal sepsis confirmed by blood-culture proof and
presence of clinical sepsis after seventh day of life (as the
definition of late-onset sepsis in this study) during the studyperiod was compiled from the records of the infection
control term. We enrolled neonates with PDA confirmed by
color Doppler as the study group and a group of gestational
age and birth body weight-matched neonates with LOS as
the controls. Neonates with cyanotic congenital heart
disease or complicated heart disease were excluded from
this study. The clinical manifestations, demographic char-
acteristics, treatments, and outcomes were recorded and
compared between the two groups.
In our NICU, attending physicians and residents routinely
check the heart sound daily, and portable cardiac color
Doppler examination is arranged for those neonates with
audible heart murmur. The cardiologists were available
every day. We tended to arrange early and aggressive
interventions, including intravenous indomethacin or
surgical ligation for symptomatic PDA, but prophylactic
ibuprofen was not used. The decisions regarding when and
whether medical treatment or surgical interventions are
employed vary between different attending physicians and
according to clinical conditions.
2.2. Definitions
Late-onset sepsis in this study was defined as the presence of
clinical sepsis and at least one positive blood culture ob-
tained from a peripheral vein after the seventh day of life.
The diagnosis of clinical sepsis was based on the presence of
3 of these symptoms: apnea; difficult breathing; cyanosis;
tachycardia or bradycardia; perfusion deficit; shock; leth-
argy; seizure; abdominal distension; vomiting; dietary
intolerance; fever or thermal instability; petechiae;
purpura; coffee-ground material from oral-gastric tubes;
hyper-or hypoglycemia; and a generally poor appearance. If
multiple positive blood cultures from a single patient showed
the same organism with an identical antibiotic susceptibility
pattern, they were considered as a single episode. If the
same organism was cultured 14 days after starting appro-
priate antibiotic therapy or if a different organism was
cultured from a subsequent culture, this was considered an
unrelated episode. If any blood culture yielded coagulase-
negative Staphylococcus (CoNS) or Staphylococcus aureus,
the associated episode was reviewed and included only if the
modified criteria from the Centers for Disease Control and
Prevention for CoNS and S aureus sepsis were met.22e24
Sepsis-contributed mortality was defined as lethal within 3
days after onset, death resulting from infectious complica-
tions, or progressive multi-organ failure until death.
2.3. Statistical methods
The first and recurrent episodes of LOS in this study were
considered as independent events. The Chi-squared,
Late-onset sepsis in PDA 311Fisher exact, and nonparametric tests were used for
categorical data, and either the Student t test or the
Wilcoxon/ManneWhitney test was used for continuous
variables. A p value <0.05 was considered to be statisti-
cally significant. All statistics were performed using the
commercially available software SPSS software for
Windows (version 13.0; SPSS, Inc., Chicago, IL, USA).3. Results
From January 2003 to December 2009, a total of 224
neonates were confirmed to have at least one event of
blood culture-proven LOS and 79 (35.3%) of these were
documented to have PDA in our neonatal database. Another
79 gestational age- and birth body weight-matched
neonates with LOS during the same period were selected
as the controls. The demographic characteristics of
neonates with and without PDA are compared in Table 1.
Although neonates with and without PDA were comparable
in both gestational age and birth body weight, neonates
with PDA required a significantly longer period of ventilator
support and duration of hospitalization (p Z 0.001 and
p Z 0.005, respectively) than those without PDA if they
experienced LOS. Neonates with PDA also had significantly
higher rates of respiratory distress syndrome (RDS) and
bronchopulmonary dysplasia (BPD; both p < 0.001) than
those without PDA. A total of 104 episodes of LOS occurred
in these 79 neonates with PDA, while 94 episodes of LOS
were noted in the control group. The onset age of sepsis
was not significantly different between these two groups,
and neonates with PDA had a relatively higher rate of
recurrent sepsis than those without PDA (25.3% vs. 15.2%,
p Z 0.079).Table 1 Demographic characteristics of neonates with late-on
without PDA.
Characteristics
Total patients number
Total episodes of sepsis
Birth body weight (g) (mean  SD)
Gestational age (weeks) (mean  SD)
Hospital stay before first episode of
late-onset sepsis (days) (median, IQR)
Gender (male/female)
Personal history
Respiratory distress syndrome (with Surventa use) (n, %)
Necrotizing enterocolitis (definite,  Stage II) (n, %)
Surgical intervention* (n, %)
Gastrointestinal tract anomalies (n, %)
Bronchopulmonary dysplasia (n, %)
Intraventricular hemorrhage ( Grade II)
Cholestasis (n, %)
Experience of recurrent sepsis (n, %)
Duration of ventilator use (days) (median, IQR)
Duration of hospitalization (days) (median, IQR)
Final mortality (n, %)
IQR Z interquartile range; PDA Z patent ductus arteriosus; SD Z sta
* Including surgical intervention for complicated CHD, VP-shunt, suAmong these 79 neonates with PDA, more than half (43/
79, 54.4%) also had atrial septal defect (ASD), and four
neonates had PDA, ASD and ventricular septal defect (VSD)
simultaneously. In these 79 neonates with PDA with/
without ASD or VSD, 11 were spontaneously closed and
therapeutic interventions were given at median age of 10.0
(range 3 to 80) days in 65 neonates, including 14 treated
successfully by intravenous indomethacin and 51 by surgical
ligation (Table 2). Three neonates with symptomatic PDA
were not treated, one with pulmonary hypertension and
later Eisenmenger’s syndrome and the other two who were
critically ill and experienced septic shock, all of three of
whom finally died. None of these 43 neonates with
untreated ASD or VSD experienced tachycardia, ventilator
dependence or symptoms of congestive heart failure after
their PDA was closed. Only oral diuretics (behyde and
aldatone) were given for later BPD. Of these 69 neonates
with symptomatic PDA, 85 (93.4%) of their total 91 episodes
of LOS occurred after their PDAs were closed. Only 5
neonates with PDA experienced LOS and congestive heart
failure and/or septic shock at the same time, all of whom
had their PDA ligation performed after the hemodynamic
conditions were stabilized.
The microorganisms causing LOS in neonates with and
without PDA are listed in Table 3. There were no significant
differences between these two groups in the distribution of
Gram-positive and Gram-negative microorganisms, poly-
microbial sepsis or ESBL-producing bacteria. All of our
patients received systemic antimicrobials immediately
after septic work-up and the empirical antibiotics for late-
onset sepsis usually included oxacillin or vancomycin plus
gentamicin. For severe infection, cefotaxime or ceftazi-
dime was substituted for gentamicin. A carbapemen
regimen was used in some infants to treat ESBL-producingset sepsis and the comparisons between neonates with and
Neonates with PDA Neonates without PDA p
79 79
104 94
1149.7  424.9 1184.9  399.2 0.563
28.3  3.3 28.9  2.8 0.107
26.5 (16e40) 28 (17e48) 0.124
41/38 44/35 0.557
69 (87.3) 52 (65.8) <0.001
6 (7.6) 7 (8.8) 0.798
6 (7.6) 7 (8.8) 0.798
4 (5.1) 3 (3.8) 0.707
64 (81.0) 48 (61.0) 0.002
11 (13.9) 8 (10.1) 0.490
19 (24.1) 14 (17.7) 0.185
20 (25.3) 12 (15.2) 0.076
54.0 (36.0e86.0) 39.0 (22.5e62.5) 0.001
85.0 (62.0e122.0) 66.0 (53.5e95.0) 0.005
7 (8.9) 5 (6.3) 0.576
ndard deviation.
rgical abdomen, necrotizing enterocolitis, but not PDA ligation.
Table 2 Symptoms and treatments of 104 neonates with late-onset sepsis.
Tapes of congenital heart disease, the symptoms and treatment Patient number %
Total patient number 79 100
Neonates with symptomatic PDA 69 87.3
Asymptomatic PDA 10 12.7
Symptoms of PDA
Tachycardia 64 81
Clinical pulmonary hemorrhage* 9 11.4
Ventilator dependent 59 74.7
Congestive heart failurey with/without cardiomegaly 30 38.0
Tachypnea, or apnea and desaturation 38 48.1
Asymptomatic patients 10 12.7
Treatment of patent ductus arteriosus
Spontaneously closure 11 13.9
Closed by indomethacin/Ibuprofen 14 17.7
Surgical ligationz 51 64.6
No treatmentx 3 3.8
Days of life starting therapy for PDA (days) (median, IQR) 10.0 (7.0-18.0)
IQR Z interquartile range; PDA Z patent ductus arteriosus.
* Presenting as bloody material from endotracheal tube.
y Defined as those requiring cardiac inotropic agents (e,g. Dopamine, dobutamine, epinephrine), diuretics (furosemide) or more
ventilator support.
z Included neonates with previous failure of indomethacin/ibuprofen treatment.
x Symptomatic PDA which was not suitable for any managements.
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prescribed once the susceptibility of blood culture was
obtained.
The clinical symptoms of late-onset sepsis in neonates
with and without PDA were not significantly different
(Table 4). Apnea with/without bradycardia and cyanosisTable 3 The distribution of pathogens causing late-onset sepsi
Pathogens of late-onset sepsis
Total episodes (n)
Gram-positive organisms (total n Z 116)
Staphylococcus-coagulase negative (n, %)
Staphylococcus aureus (n, %)
Enterococcus spp. (n, %)
Gram-negative organisms (total n Z 80)
Escherichia coli (n, %)
Klebsiellay (n, %)
Pseudomonas (n, %)
Enterobacterz (n, %)
Acinetobacter baumannii (n, %)
Serratia marcescens (n, %)
Sepsis caused by polymicrobial pathogens (n, %)
ESBL-producing organisms* (total n Z 12)
Klebsiella pneumonia-ESBL (n, %)
Klebsiella oxytoca-ESBL (n, %)
Enterobactor cloacae-ESBL (n, %)
CHD: congenital heart disease; ESBL-producing organisms: extended-
* ESBL-producing organisms were included in the Gram-negative org
y Includes K. oxytoca and K. pneumoniae.
z Includes E. cloacae and E. aerogenes.was the most common clinical manifestation, followed by
feeding intolerance and fever. However, neonates with PDA
had a significantly higher requirement of respiratory
support at onset of sepsis than those without PDA, including
a higher rate of mechanical ventilation (41.3% vs. 22.3%,
p Z 0.001) and a significantly lower rate of off-ventilators in neonates with and without congenital heart disease.
Neonates with PDA Neonates without PDA
104 94
59 (56.7) 57 (60.1)
41 (39.4) 39 (41.5)
15 (14.4) 14 (14.9)
3 (2.9) 4 (4.3)
44 (42.3) 36 (38.3)
8 (7.7) 7 (7.4)
21 (20.2) 15 (15.9)
2 (1.9) 2 (2.1)
7 (6.7) 8 (8.5)
4 (3.8) 3 (3.2)
2 (1.9) 1 (1.1)
1 (1.0) 1 (1.1)
7 (6.7) 5 (5.3)
5 (4.8) 2 (2.1)
1 (1.0) 1 (1.1)
1 (1.0) 2 (2.1)
spectrum b-lactamase-producing bacteria.
anisms.
Table 4 The comparisons of clinical manifestations of late-onset sepsis between neonates with and without CHD.
Neonates with PDA Neonates without PDA p
Total episodes of late-onset sepsis 104 94
Clinical symptoms of late-onset sepsis
Fever (n, %) 37 (35.6) 29 (30.8) 0.730
Apnea  bradycardia and cyanosis (n, %) 94 (90.4) 81 (86.1) 0.425
Feeding intolerance  ileus or abdominal distension (n, %) 69 (66.3) 64 (68.1) 0.819
Hypotension (n, %) 11 (9.6) 7 (7.4) 0.221
Coagulopathy (prolonged PT and/or APTT)  DIC (n, %) 22 (21.2) 17 (18.1) 0.879
Metabolic acidosis (n, %) 31 (29.8) 23 (24.5) 0.243
Ventilator requirement at onset of sepsis <0.001
Room air or O2 hood (n, %) 8 (7.7) 26 (27.7) <0.001
Nasal canula (n, %) 4 (3.8) 5 (5.3) NS
Nasal-continuous positive airway pressure (CPAP; n, %) 19 (18.3) 22 (23.4) NS
Nasal-IMV (intermittent mandatory ventilator; n, %) 25 (24.0) 17 (18.1) NS
Mechanical ventilator (intubation with IMV; n, %) 43 (41.3) 21 (22.3) 0.001
High frequency oscillatory ventilator (HFOV; n, %) 5 (4.8) 3 (3.2) NS
DIC Z disseminated intravascular coagulopathy; PDA Z patent ductus arteriosus.
Late-onset sepsis in PDA 313support (27.7% vs. 7.7%, p < 0.001), which was consistent
with their significantly longer duration of ventilator use in
the NICU (Table 1).
A total of 7 neonates (8.9%) of our study group died,
which was not significantly different from neonates without
PDA (5/79, 6.3%) (p Z 0.576). Five of these deaths were
sepsis-contributed mortalities, including one with pulmo-
nary hypertension and later Eisenmenger’s syndrome and
two with worsening congestive heart failure due to PDA.
One patient died of sudden infant death without defined
etiology. The last one was found to have intracardiac
thrombosis during an episode of CoNS sepsis and resusci-
tation during cardiac arrest proved unsuccessful.4. Discussion
This study aimed to investigate whether neonates with
PDA were more vulnerable to mortality or morbidity if they
experienced LOS. We found that, although most neonates
had their PDA closed before onset of sepsis, they still had
a higher rate of BPD and a relatively higher rate of recur-
rent sepsis. Neonates with PDA also required longer dura-
tions of ventilator support and were hospitalized longer
than those without PDA. In contrast to most other studies
about CHD of premature neonates, which evaluated the
postoperative course and outcome after open-heart
surgery,19,25e28 our study tended to delineate the hospital
course of neonates with PDA and who experienced LOS. The
study group and control group were matched for both birth
body weight and gestational age, but neonates with PDA
had a significantly higher rate of RDS, which may result in
higher rate of BPD and cholestasis. We can conclude that
hemodynamically significant PDA contributes to the
complexity of hospitalization by the relative compromised
cardiovascular function and the associated existence of
RDS.
In our NICU, we tended to have early interventions of
PDA in extremely preterm infants, since late surgicalclosure of PDA (>3 weeks of life) has been documented to
be associated with delay of full oral feeding and decreased
body growth when compared with early surgical
closure.29,30 However, a critically ill condition or septic
shock may postpone early intervention of symptomatic
PDA. Fourteen of 68 neonates with symptomatic PDA had
their surgical ligation after 3 weeks. The dilemma of
managing a neonate with septic shock and cardiogenic
heart failure is a challenge to neonatologists since fluid
restriction is required for PDA with congestive heart failure
but intravenous volume expansion is necessary for neonates
with septic shock. In hemodynamically significant PDA,
especially those of VLBW infants and in those where closure
was difficult by indomethacin, emergent PDA ligation for
a septic neonate was performed. This dangerous situation
should be avoided due to the higher risk of morbidity.
Recent publications have concluded that routine screening
in VLBW neonates for detection of early ductal shunting and
closure of the PDA before vasopressor should be considered
in hypotensive infants.31,32
The significantly longer hospitalization of neonates with
PDA may result from the higher rate of BPD and longer
requirement of ventilator support. However, the relatively
higher rate of recurrent sepsis in neonates with PDA was
another reason because the septic conditions would extend
the duration of feeding intolerance and result in more
requirement of ventilator support and central venous
catheters for intravenous antibiotics, which in turn make
patients more likely to have subsequent nosocomial infec-
tions, such as ventilator-associated pneumonia, catheter-
related sepsis, or bacteremia. Although most of our
episodes of LOS occurred after closure of PDA, untreated
ASD or VSD may still contribute to relative pulmonary
congestion and subsequent difficulty of weaning patients
off the ventilator because of the left-to-right shunting.
An increased incidence of PDA in VLBW neonates, as
compared to the general population, has been noted in
recent publications.33,34 A better surveillance system of
monitoring for bacteremia or septic conditions is warranted
314 P.-J. Chiang et aland more aggressive treatments are necessary for VLBW
infants with PDA. This study is limited by its inadequate
case numbers and its failure to conclude whether early
intervention of PDA in VLBW is superior to delayed PDA
management. Another limitation of our study is its retro-
spective design and there might also be selection bias for
this matched case-control study.
In conclusion, neonates with PDA are more likely to have
complicated hospital courses if they acquire LOS during
their hospitalization. Evaluation for early ductal shunting
and closure of the PDA should be attempted before
cardiogenic heart failure is encountered and vasopressor is
considered. Close monitoring and aggressive treatments are
warranted in these susceptible cases of LOS.References
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